What is a characteristic of primary hyperaldosteronism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hypertension is the Characteristic Feature of Primary Hyperaldosteronism

The correct answer is (c) hypertension, which is the most common and characteristic feature of primary hyperaldosteronism.

Pathophysiology of Primary Hyperaldosteronism

Primary hyperaldosteronism (also called primary aldosteronism) is characterized by:

  • Excessive and autonomous production of aldosterone by the adrenal glands, independent of the renin-angiotensin system 1, 2
  • Hypertension, which is present in virtually all patients and is often resistant to conventional treatment 1
  • Suppressed plasma renin activity (hypo-reninism, not hyper-reninism) due to negative feedback from excess aldosterone 1, 2
  • Sodium retention and increased potassium excretion 1, 3

Why Hypertension is the Correct Answer

Hypertension is the hallmark clinical manifestation of primary hyperaldosteronism for several reasons:

  • Recent studies indicate that primary aldosteronism is present in approximately 5-10% of all hypertensive patients, with prevalence increasing to 13% among patients with severe hypertension (180/110 mmHg) 1
  • Among patients with resistant hypertension, the prevalence of primary aldosteronism is even higher at approximately 20% 1
  • Hypertension occurs due to excessive aldosterone causing increased sodium and water retention, leading to expanded plasma volume and increased peripheral vascular resistance 2, 4

Why the Other Options are Incorrect

  • (a) Hyperkalemia: Primary hyperaldosteronism typically causes hypokalemia (low potassium), not hyperkalemia, due to increased urinary potassium excretion driven by excess aldosterone. However, hypokalemia is a late manifestation and is absent in the majority of cases 1, 5

  • (b) Hyper-reninism: Primary hyperaldosteronism causes hypo-reninism (suppressed renin), not hyper-reninism. The excessive autonomous aldosterone production suppresses renin release through negative feedback 1, 2

  • (d) Hyperplasia of zona reticularis: The zona reticularis produces androgens, not aldosterone. Primary hyperaldosteronism involves the zona glomerulosa, which is the site of aldosterone production 2

  • (e) Hyperplasia of zona fasciculata: The zona fasciculata produces cortisol, not aldosterone. In primary hyperaldosteronism, the pathology involves the zona glomerulosa 2

Clinical Implications

  • Screening for primary hyperaldosteronism is recommended in patients with resistant hypertension, hypokalemia, adrenal incidentaloma, family history of early-onset hypertension, or stroke at a young age 1, 5
  • The aldosterone-to-renin ratio is the recommended screening test, with a common cutoff value of 30 when plasma aldosterone concentration is reported in ng/dL and plasma renin activity in ng/mL/h 1, 2
  • Compared to primary hypertension, primary aldosteronism causes more end-organ damage and is associated with excess cardiovascular morbidity, including heart failure, stroke, myocardial infarction, and atrial fibrillation 1, 6

Treatment Approach

  • Unilateral laparoscopic adrenalectomy is the treatment of choice for unilateral disease (usually aldosterone-producing adenoma), which improves blood pressure in nearly 100% of patients and achieves complete cure of hypertension in approximately 50% 1, 4
  • Medical therapy with mineralocorticoid receptor antagonists (MRAs), particularly spironolactone, is the cornerstone of treatment for bilateral disease (idiopathic hyperaldosteronism) 4
  • Spironolactone dosing for primary hyperaldosteronism typically ranges from 100 mg to 400 mg daily 4

Understanding that hypertension is the characteristic feature of primary hyperaldosteronism is crucial for proper clinical recognition and management of this common but often underdiagnosed cause of secondary hypertension.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Primary Aldosteronism: Pathophysiology and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Relationship between Primary Aldosteronism and Stroke

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management and Treatment of Primary Hyperaldosteronism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.